📢 NEW FDA APPROVAL marks a milestone for #PFA.
Introducing the FARAPOINT™ Pulsed Field Ablation (PFA) Catheter—the first and only focal catheter designed and optimized for PFA—built on the proven FARAPULSE™ PFA Platform. FARAPOINT creates deep, durable focal and linear-shaped lesions in a single catheter, unlocking new possibilities for optimized point-by-point workflows for CTI ablations.
Explore FARAPOINT: https://t.co/rKkllURy92
#Epeeps #PulsedFieldAblation
FARAPULSE™ Pulsed Field Ablation System Indications, Safety, and Warnings: https://t.co/A64fZE9GVn
OPAL HDx™ Mapping System Indications, Safety, and Warnings: https://t.co/wu777PHkBb
OPTIMIZE has begun! This trial pairs the Cortex OPTIMAP™ Electrographic Flow (EGF) Mapping Technology with the FARAPULSE™ PFA Platform to explore a more personalized approach to AF treatment—evaluating how EGF-guided mapping and #PFA ablation of AF sources may improve outcomes for patients with persistent AF.
Congrats to Dr. @omwazni, Global Principal Investigator, on completing the first case!
Learn more: https://t.co/G5JMSdw9Xn
The first-ever FARAFLEX™ Mapping and Pulsed Field Ablation (PFA) Catheter case was completed at KBC Split in Split, Croatia as part of the premarket ELEVATE-PF feasibility study performed by Dr. Anic and observed by Drs. Wazni and Saliba.
Our innovation and clinical investment in FARAFLEX continue to position Boston Scientific as a leader in #PFA to further the treatment of cardiac arrhythmias.
Learn more about FARAPULSE Pulsed Field Ablation System: https://t.co/6XhIwkXuUK #EPeeps #PFA
The next-level FARAPULSE™ mapping experience is here! The first FARAVIEW™ cases are officially beginning in the United States.
We’re excited to provide physicians the next leap forward in mapping for the leading PFA system and to deliver confidence in PFA visualization.
Learn more about how the FARAVIEW Software Module on the OPAL HDx™ Mapping System can transform your visual experience: https://t.co/OZTAwtx6UE
#PFAonFARAVIEW
Safety Info: https://t.co/AICP329NCR
We are excited to announce the FDA’s 510(K) clearance of the FARAVIEW™ Software Module and the FDA approval of the FARAWAVE™ NAV #PulsedFieldAblation Catheter. Together, these advancements provide an integrated PFA solution with a single catheter for mapping and ablation.
Join John Day, MD and Vivek Reddy, MD on August 19 at 8pm – 9pm EDT for an insightful case review and a discussion on FARAPULSE integration into mapping! 👉 https://t.co/4dkh28rYyJ
Plus, get your questions answered by the faculty live 🗣️ #EPeeps#EP#TransformAF#FARAPULSE
*Pending 510(k) clearance, not available for sale in the United States. CAUTION: Investigational Device. Limited by Federal (or US) law to investigational use only. Not available for sale.
Attention #EPeeps – mark your calendars as you don’t want to miss any of the FARAPULSE™ #PFA late breakers being presented at #HRS2024 starting Friday, May 17thAttention #EPeeps – mark your calendars as you don’t want to miss any of the FARAPULSE™ #PFA late breakers being presented at #HRS2024 starting Friday, May 17thAttention #EPeeps – mark your calendars as you don’t want to miss any of the FARAPULSE™ #PFA late breakers being presented at #HRS2024 starting Friday, May 17th.
#EPeeps
What’s the rate of PV reconnection post thermal PVI in pts with pers AF + dilated/ scarred LA?
We @LiverpoolEP performed a mandated 2-month repeat study in 38pt. Half of all PVs were reconnected!
Now online in @hrs_journal@DhirajGuptaBHRS
https://t.co/FR2rbqkZdi
#PFA is highly efficient for #epAblation following prior #RFA, which may be beneficial in pts presenting for redo procedures. In the ventricle, PFA resulted in lesions that are deeper than RFA when ablating over chronic superficial RFA lesions. https://t.co/DTkftHm96X #JACCCEP
Did my 1st Farapulse case today. @bostonsci@BSCCardiology. Couldn’t find the fluoro pedal today, didn’t need it. Cases went super smooth . @AdventHealth
1/ Today we want to celebrate the first US commercial cases using the FARAPULSE™ PFA System.
To kick us off, congrats to Dr. @VivekReddyMD and the team at @MountSinaiHeart for being a part of this milestone and completing your first commercial FARAPULSE™ cases!
The FARAPULSE™ Pulsed Field Ablation System is now FDA approved! This innovative technology will accelerate the growth of our electrophysiology portfolio and enable physicians to treat more patients with #AFib worldwide. #PulsedFieldAblation Learn more: https://t.co/ACClFksiOD